Human Resources
Top 5 talent acquisition & recruitment trends shaping 2021 – Interview
Human Resources: The Australian Pharma, MedTech and Biotech sectors have spent much of the past ten months adapting to extraordinary circumstances and navigating a new way of working internally and externally in servicing their customers.
In an interview with Health Industry Hub, subject matter expert, Vanessa Meikle from Hunton Executive explores the key trends in talent acquisition and recruitment shaping 2021.
Key trends explored:
- The impact of the COVID-19 pandemic on the Australian Pharma, MedTech and Biotech workforce.
- The organisational roles impacted the least and those that grew in demand during this time.
- Talent gaps in the post-COVID era to drive organisational growth.
- Top 5 workforce trends to watch in 2021.
- Key tips for leaders navigating the new normal, and for individuals currently looking for employment in the Pharma, MedTech and Biotech sectors.
About Vanessa Meikle
Vanessa Meikle is the CEO and Founder of Hunton Executive. She is an executive search management consultant and executive career coach with over 18 years’ experience specifically within the life sciences and healthcare industries. She helps employers accelerate their business performance through the attraction, recruitment, and retention of their leaders and she helps executives accelerate their careers by guiding them through their career transition and accessing career defining job opportunities.
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More